Antibiotic Therapy in the Treatment of COVID-19 Pneumonia: Who and When?
Background: COVID-19 imposes challenges in antibiotic decision-making due to similarities between bacterial pneumonia and moderate to severe COVID-19. We evaluated the effects of antibiotic therapy on the clinical outcomes of COVID-19 pneumonia patients and diagnostic accuracy of key inflammatory ma...
Saved in:
Main Authors: | Tat Ming Ng (Author), Sean W. X. Ong (Author), Audrey Y. X. Loo (Author), Sock Hoon Tan (Author), Hui Lin Tay (Author), Min Yi Yap (Author), David C. Lye (Author), Tau Hong Lee (Author), Barnaby E. Young (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study
by: Sean W. X. Ong, et al.
Published: (2022) -
Hospitalised patients as stewards of their own antibiotic therapy: a qualitative analysis informing the strategic design of interventions to encourage shared decision-making in tertiary hospital settings in Singapore
by: Huiling Guo, et al.
Published: (2024) -
The Associations between Poor Antibiotic and Antimicrobial Resistance Knowledge and Inappropriate Antibiotic Use in the General Population Are Modified by Age
by: Huiling Guo, et al.
Published: (2021) -
When Antibiotics Appear to Fail
by: Gilles R. G. Monif
Published: (1997) -
Are alternative antibiotics needed for antibiotic-nonresponsive pneumonia?
by: Eun-Ae Yang, et al.
Published: (2020)